Evidence map›Paper›PMID 22814860›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2012

Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice.

Katherine Kolor, Debra Duquette, Amy Zlot, Joan Foland, Beth Anderson, Rebecca Giles, Jennifer Wrathall, Muin J Khoury

Abstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. From public health genomics to precision public health: a 20-year journey.Genetics in medicine : official journal of the American College of Medical Genetics · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Public Awareness of Direct-to-Consumer Genetic Tests: Findings from the 2013 U.S. Health Information National Trends Survey.Journal of cancer education : the official journal of the American Association for Cancer Education · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katherine KolorOffice of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. kkolor@cdc.gov
Debra Duquette
Amy Zlot
Joan Foland
Beth Anderson
Rebecca Giles
Jennifer Wrathall
Muin J Khoury

Funding

HEALTHY COMMUNITIES, TOBACCO CONTROL, DIABETES PREVENTION AND CONTROL, AND BEHAVIU58DP002006 · DP · CONNECTICUT STATE DEPT OF PUBLIC HEALTH · PI WALSH, BARBARA METCALF · 2009 to 2014
$10.3M
Intramural NIH HHS Z99 CA999999NCCDPHP CDC HHS 3U58/DP002006-01W1NCCDPHP CDC HHS U58 DP002006OGDP CDC HHS 1U38GD000061OGDP CDC HHS 5U38GD000054OGDP CDC HHS U38 GD000054OGDP CDC HHS U38 GD000061
6 · The paper itself

Abstract

purposeDirect-to-consumer personal genomic tests are widely available, but population-based data are limited on awareness and use of these tests among the general public in the United States.

methodsWe assessed awareness and use of direct-to-consumer personal genomic tests in Connecticut, Michigan, Oregon, and Utah using the 2009 Behavioral Risk Factor Surveillance System and compared the state results to the 2008 national HealthStyles survey results.

resultsAwareness was the highest in Oregon (29.1%) and the lowest in Michigan (15.8%). Factors associated with awareness across all states and nationally were higher education, higher income, and increasing age, except among those 75 years or older. Less than 1% of respondents had used the tests, with about one-half to three-quarters of those sharing the results with a health-care provider.

conclusionsAwareness of direct-to-consumer genetic tests is greater in this study as compared with a related study conducted in 2006, whereas use is similarly low in both studies. The few respondents who reported using the tests often reported sharing their results with their health-care provider, indicating an important opportunity for health-care providers to offer patient education regarding these tests. Public health agencies have important roles in surveillance, education, and policy development on direct-to-consumer genomic tests.

Indexed as

Health Knowledge, Attitudes, PracticeAge FactorsBehavioral Risk Factor Surveillance SystemConsumer Health InformationEducational StatusGenetic TestingHealth SurveysHumansSocioeconomic FactorsUnited States

Identifiers

PMID22814860
PMCPMC5624323

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.